YOLFTbeta
Prodia Widyahusada Tbk PT

Prodia Widyahusada Tbk PT

PRDA · JK · Healthcare / Diagnostics & Research

3,570.00IDR-50.00 (-1.38%)

Price History

Full chart

Market Stats

Previous Close3,620.00
Open3,640.00
Day Range3,530.00 – 3,650.00
52-Week Range2,146.71 – 2,940.00
Volume536.00K
Market Cap2.56T
P/E (TTM)11.82
Forward P/E9.72
EPS243.59
Dividend Yield5.77%
Beta0.03
50-Day Avg2,605.00
200-Day Avg2,496.80

About

PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Liana Kuswandi
  • Employees2.91K
  • HeadquartersProdia Tower, Jakarta Pusat, Indonesia, 10430, Indonesia
  • Websitehttps://prodia.co.id/id

Leadership

  • Ms. Liana KuswandiPresident Director · b. 1973
  • Ms. Marina Eka AmaliaFinance and Sustainability Director, Head of Legal, Corporate Secretary & Director
  • Ms. Ida ZuraidaPeople & Organizational Development Director and Director · b. 1977
  • Ms. Indriyanti Rafi SukmawatiCommercial & Partnership Director and Director · b. 1972
  • Mr. Andri HidayatIntegrated Solutions & Diagnostic Director and Director · b. 1973
  • Ms. Sri PaulaniHead of Internal Audit · b. 1971

Financials

Income Statement

Currency: IDR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue997.99B1.10T1.20T1.36T1.47T1.60T1.74T1.87T2.65T2.18T2.22T2.25T2.28T
Growth (%)-+10.33%+8.78%+13.44%+7.90%+9.12%+9.03%+7.40%+41.58%-17.74%+1.87%+1.34%+1.31%
Cost of Revenue395.98B464.07B511.19B565.28B612.49B656.95B703.26B827.15B1.02T854.53B957.10B900.17B1.15T
Gross Profit602.01B636.98B686.53B793.38B853.53B942.81B1.04T1.05T1.63T1.33T1.27T1.35T1.13T
Gross Margin60.32%57.85%57.32%58.39%58.22%58.93%59.68%55.85%61.56%60.83%56.94%60.03%49.71%
Operating Expense508.08B546.17B589.59B663.78B703.77B762.89B824.96B744.46B876.08B880.07B956.86B1.05T907.22B
Operating Income93.93B90.81B96.94B129.60B149.76B179.92B216.05B301.76B756.63B447.04B308.50B300.50B227.11B
Operating Margin9.41%8.25%8.09%9.54%10.22%11.25%12.39%16.11%28.53%20.49%13.88%13.34%9.95%
EBITDA120.12B121.48B131.80B182.65B272.70B311.36B357.08B490.77B948.89B629.26B478.95B515.61B464.65B
EBITDA Margin12.04%11.03%11.00%13.44%18.60%19.46%20.47%26.20%35.78%28.84%21.55%22.89%20.36%
Net Income61.59B58.56B59.02B88.13B150.80B175.45B210.26B268.75B623.23B371.65B259.87B270.20B206.79B
Net Income Margin6.17%5.32%4.93%6.49%10.29%10.97%12.05%14.35%23.50%17.04%11.69%12.00%9.06%
R&D--2.01B1.57B5.09B2.79B3.92B2.63B2.05B3.12B1.85B5.87B4.49B
R&D as % of Total Revenue--0.17%0.12%0.35%0.17%0.22%0.14%0.08%0.14%0.08%0.26%0.20%
Interest Expense12.03B20.52B25.66B16.47B16.34B13.20B11.65B12.44B14.91B12.03B12.72B9.38B9.72B
Interest Expense % of Total Revenue1.21%1.86%2.14%1.21%1.11%0.83%0.67%0.66%0.56%0.55%0.57%0.42%0.43%

Balance Sheet

Currency: IDR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets513.64B634.33B577.87B1.82T1.85T1.93T2.01T2.23T2.72T2.67T2.71T2.84T2.70T
Total Liabilities425.31B500.08B451.54B556.78B485.11B368.21B351.37B443.75B466.27B358.45B347.45B355.45B302.48B
Total Equity87.25B134.42B126.33B1.27T1.36T1.56T1.66T1.79T2.25T2.31T2.36T2.48T2.39T
Cash34.58B45.11B44.98B1.18T788.43B102.48B91.85B364.99B607.83B698.40B542.96B441.80B589.08B
Total Debt133.82B165.89B76.43B107.43B61.62B43.05B21.86B43.90B32.90B31.54B31.36B30.34B20.87B
Net Debt99.24B120.77B30.03B-1.07T-726.81B-59.44B-69.99B-321.09B-574.94B-666.86B-511.60B-411.46B-568.21B

Cash Flow

Currency: IDR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow82.66B105.66B155.61B119.25B93.47B239.83B341.82B434.63B777.27B496.73B411.29B476.64B424.13B
Investing Cash Flow-58.95B-122.64B63.41B-72.42B-409.11B-844.27B-241.74B5.66B-333.44B65.39B-244.27B-299.78B54.89B
Financing Cash Flow-14.17B27.50B-219.16B1.09T-73.43B-81.50B-110.72B-167.16B-200.98B-434.59B-322.46B-278.02B-331.74B
Capital Expenditure68.96B129.11B321.78B77.17B209.82B191.71B82.71B143.76B207.33B235.30B245.82B225.11B72.58B
Free Cash Flow13.71B-23.46B-166.17B42.08B-116.35B48.12B259.11B290.87B569.94B261.44B165.46B251.53B351.56B
Dividends Paid74.52B58.00B100.00B75.00B26.44B60.32B87.72B105.13B161.25B372.97B222.99B155.59B162.12B
FCF to OCF16.58%-22.20%-106.79%35.29%-124.48%20.06%75.80%66.92%73.33%52.63%40.23%52.77%82.89%
Dividend Paid to FCF543.64%-247.28%-60.18%178.23%-22.72%125.35%33.86%36.14%28.29%142.66%134.77%61.86%46.11%

Earnings

Report DateApr 27, 2017Jul 31, 2017Oct 26, 2017Mar 22, 2018Apr 30, 2018Jul 27, 2018Oct 30, 2018Mar 22, 2019Apr 29, 2019Jul 30, 2019Oct 30, 2019Mar 10, 2020Jun 30, 2020Jul 31, 2020Nov 5, 2020Mar 12, 2021May 3, 2021Aug 4, 2021Nov 2, 2021Mar 15, 2022Jun 20, 2022Jul 29, 2022Oct 31, 2022Mar 15, 2023May 3, 2023Aug 3, 2023
EPS Estimate--------------------------
EPS Actual34.4628.2042.8455.3534.6730.2448.6873.5551.1635.9841.9095.2437.10-50.00143.33156.23169.33151.76224.07113.92111.2757.70122.04102.8775.8982.18
Surprise--------------------------
TimingPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap2.56T
Enterprise Value1.88T
Trailing P/E11.82
Forward P/E9.72
Price / Sales1.08
Price / Book1.09
EPS243.59
Book Value2,629.33
Revenue (TTM)2.37T
Gross Profit (TTM)1.37T
EBITDA356.60B
Profit Margin9.06%
Operating Margin11.32%
Return on Equity9.22%
Return on Assets5.93%
Shares Outstanding889.78M
Shares Float242.90M
Beta0.03
Dividend Yield5.77%
Dividend Rate162.68
Payout Ratio68.21%

Dividends

20261×
162.68May 5, 2026
20251×
172.93May 8, 2025
20241×
165.97Apr 29, 2024
20231×
237.85May 2, 2023
20221×
397.84Apr 19, 2022
20211×
172.00Apr 19, 2021
20201×
112.14May 4, 2020
20191×
93.57May 13, 2019
20181×
64.40May 16, 2018